Trial result

The mRNA Cancer Vaccine Story Just Got Less Comfortable

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Polycythemia Vera Gets a First-in-Class Option. Patients Need More Than Blood Draws.

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

MS Gets a Cleaner BTK Signal

Novartis lowered Lp(a) but not cardiovascular risk. What went wrong?

AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial

Endometrial Cancer Prehab Should Not Be a Luxury Experiment

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
